Anne Ng'ang'a1, Wanjiru Waruiru, Carol Ngare, Victor Ssempijja, Thomas Gachuki, Inviolata Njoroge, Patricia Oluoch, Davies O Kimanga, William K Maina, Rex Mpazanje, Andrea A Kim. 1. *National AIDS and Sexually Transmitted Infection (STI) Control Programme, Ministry of Health, Nairobi, Kenya; †Global Health Sciences, University of California, San Francisco, San Francisco, CA; ‡Division of Global HIV/AIDS, Center for Global Health, US Centers for Disease Control and Prevention, Nairobi, Kenya; §National Public Health Laboratory Services, Ministry of Health, Kenya; ‖Liverpool Voluntary Counselling and Testing, Nairobi, Kenya; ¶National Public Health Laboratory Services, Ministry of Health, Nairobi, Kenya; and ¶World Health Organization, Nairobi, Kenya.
Abstract
BACKGROUND: HIV testing and counseling (HTC) is essential for successful HIV prevention and treatment programs. The national target for HTC is 80% of the adult population in Kenya. Population-based data to measure progress towards this HTC target are needed to assess the country's changing needs for HIV prevention and treatment. METHODS: In 2012-2013, we conducted a national HIV survey among Kenyans aged 18 months to 64 years. Respondents aged 15-64 years were administered a questionnaire that collected information on demographics, HIV testing behavior, and self-reported HIV status. Blood samples were collected for HIV testing in a central laboratory. Participants were offered home-based testing and counseling to learn their HIV status in the home and point-of-care CD4 testing if they tested HIV-positive. RESULTS: Of 13,720 adults who were interviewed, 71.6% [95% confidence interval (CI): 70.2 to 73.1] had been tested for HIV. Among those, 56.1% (95% CI: 52.8 to 59.4) had been tested in the past year, 69.4% (95% CI: 68.0 to 70.8) had been tested more than once, and 37.2% (95% CI: 35.7 to 38.8) had been tested with a partner. Fifty-three percent (95% CI: 47.6 to 58.7) of HIV-infected persons were unaware of their infection. Overall 9874 (72.0%) of participants accepted home-based HIV testing and counseling; 4.1% (95% CI: 3.3 to 4.9) tested HIV-positive, and of those, 42.5% (95% CI 31.4 to 53.6) were in need of immediate treatment for their HIV infection but not receiving it. CONCLUSIONS: HIV testing rates have nearly reached the national target for HTC in Kenya. However, knowledge of HIV status among HIV-infected persons remains low. HTC needs to be expanded to reach more men and couples, and strategies are needed to increase repeat testing for persons at risk for HIV infection.
BACKGROUND: HIV testing and counseling (HTC) is essential for successful HIV prevention and treatment programs. The national target for HTC is 80% of the adult population in Kenya. Population-based data to measure progress towards this HTC target are needed to assess the country's changing needs for HIV prevention and treatment. METHODS: In 2012-2013, we conducted a national HIV survey among Kenyans aged 18 months to 64 years. Respondents aged 15-64 years were administered a questionnaire that collected information on demographics, HIV testing behavior, and self-reported HIV status. Blood samples were collected for HIV testing in a central laboratory. Participants were offered home-based testing and counseling to learn their HIV status in the home and point-of-care CD4 testing if they tested HIV-positive. RESULTS: Of 13,720 adults who were interviewed, 71.6% [95% confidence interval (CI): 70.2 to 73.1] had been tested for HIV. Among those, 56.1% (95% CI: 52.8 to 59.4) had been tested in the past year, 69.4% (95% CI: 68.0 to 70.8) had been tested more than once, and 37.2% (95% CI: 35.7 to 38.8) had been tested with a partner. Fifty-three percent (95% CI: 47.6 to 58.7) of HIV-infected persons were unaware of their infection. Overall 9874 (72.0%) of participants accepted home-based HIV testing and counseling; 4.1% (95% CI: 3.3 to 4.9) tested HIV-positive, and of those, 42.5% (95% CI 31.4 to 53.6) were in need of immediate treatment for their HIV infection but not receiving it. CONCLUSIONS: HIV testing rates have nearly reached the national target for HTC in Kenya. However, knowledge of HIV status among HIV-infected persons remains low. HTC needs to be expanded to reach more men and couples, and strategies are needed to increase repeat testing for persons at risk for HIV infection.
Authors: Susan Allen; Jareen Meinzen-Derr; Michele Kautzman; Isaac Zulu; Stanley Trask; Ulgen Fideli; Rosemary Musonda; Francis Kasolo; Feng Gao; Alan Haworth Journal: AIDS Date: 2003-03-28 Impact factor: 4.177
Authors: Rebecca Bunnell; John Paul Ekwaru; Peter Solberg; Nafuna Wamai; Winnie Bikaako-Kajura; Willy Were; Alex Coutinho; Cheryl Liechty; Elizabeth Madraa; George Rutherford; Jonathan Mermin Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: Davies O Kimanga; Samuel Ogola; Mamo Umuro; Anne Ng'ang'a; Lucy Kimondo; Patrick Murithi; James Muttunga; Wanjiru Waruiru; Ibrahim Mohammed; Shahnaaz Sharrif; Kevin M De Cock; Andrea A Kim Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming Journal: N Engl J Med Date: 2011-07-18 Impact factor: 91.245
Authors: Keri N Althoff; Stephen J Gange; Marina B Klein; John T Brooks; Robert S Hogg; Ronald J Bosch; Michael A Horberg; Michael S Saag; Mari M Kitahata; Amy C Justice; Kelly A Gebo; Joseph J Eron; Sean B Rourke; M John Gill; Benigno Rodriguez; Timothy R Sterling; Liviana M Calzavara; Steven G Deeks; Jeffrey N Martin; Anita R Rachlis; Sonia Napravnik; Lisa P Jacobson; Gregory D Kirk; Ann C Collier; Constance A Benson; Michael J Silverberg; Margot Kushel; James J Goedert; Rosemary G McKaig; Stephen E Van Rompaey; Jinbing Zhang; Richard D Moore Journal: Clin Infect Dis Date: 2010-06-01 Impact factor: 9.079
Authors: Warren Dalal; Daniel R Feikin; Manase Amolloh; Ray Ransom; Heather Burke; Fillet Lugalia; Alice Ouma; Kayla F Laserson; Jonathan Mermin; Robert F Breiman; Rebecca Bunnell Journal: J Acquir Immune Defic Syndr Date: 2013-02-01 Impact factor: 3.731
Authors: Martin Sirengo; Lilly Muthoni; Timothy A Kellogg; Andrea A Kim; Abraham Katana; Sophie Mwanyumba; Davies O Kimanga; William K Maina; Nicolas Muraguri; Benjamin Elly; George W Rutherford Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Augustine Talumba Choko; Nicola Desmond; Emily L Webb; Kondwani Chavula; Sue Napierala-Mavedzenge; Charlotte A Gaydos; Simon D Makombe; Treza Chunda; S Bertel Squire; Neil French; Victor Mwapasa; Elizabeth L Corbett Journal: PLoS Med Date: 2011-10-04 Impact factor: 11.069
Authors: Janet M Turan; Lynae A Darbes; Pamela L Musoke; Zachary Kwena; Anna Joy Rogers; Abigail M Hatcher; Jami L Anderson; George Owino; Anna Helova; Elly Weke; Patrick Oyaro; Elizabeth A Bukusi Journal: AIDS Patient Care STDS Date: 2018-03 Impact factor: 5.078
Authors: Davies O Kimanga; Samuel Ogola; Mamo Umuro; Anne Ng'ang'a; Lucy Kimondo; Patrick Murithi; James Muttunga; Wanjiru Waruiru; Ibrahim Mohammed; Shahnaaz Sharrif; Kevin M De Cock; Andrea A Kim Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Ishani Pathmanathan; Philip Lederer; Ray W Shiraishi; Nellie Wadonda-Kabondo; Anand Date; Blackson Matatiyo; E Kainne Dokubo Journal: Open Forum Infect Dis Date: 2016-12-15 Impact factor: 3.835
Authors: Richelle Harklerode; Wanjiru Waruiru; Felix Humwa; Anthony Waruru; Timothy Kellogg; Lilly Muthoni; James Macharia; Emily Zielinski-Gutierrez Journal: AIDS Care Date: 2019-04-27
Authors: Linda-Gail Bekker; George Alleyne; Stefan Baral; Javier Cepeda; Demetre Daskalakis; David Dowdy; Mark Dybul; Serge Eholie; Kene Esom; Geoff Garnett; Anna Grimsrud; James Hakim; Diane Havlir; Michael T Isbell; Leigh Johnson; Adeeba Kamarulzaman; Parastu Kasaie; Michel Kazatchkine; Nduku Kilonzo; Michael Klag; Marina Klein; Sharon R Lewin; Chewe Luo; Keletso Makofane; Natasha K Martin; Kenneth Mayer; Gregorio Millett; Ntobeko Ntusi; Loyce Pace; Carey Pike; Peter Piot; Anton Pozniak; Thomas C Quinn; Jurgen Rockstroh; Jirair Ratevosian; Owen Ryan; Serra Sippel; Bruno Spire; Agnes Soucat; Ann Starrs; Steffanie A Strathdee; Nicholas Thomson; Stefano Vella; Mauro Schechter; Peter Vickerman; Brian Weir; Chris Beyrer Journal: Lancet Date: 2018-07-20 Impact factor: 79.321
Authors: Martin Sirengo; Lilly Muthoni; Timothy A Kellogg; Andrea A Kim; Abraham Katana; Sophie Mwanyumba; Davies O Kimanga; William K Maina; Nicolas Muraguri; Benjamin Elly; George W Rutherford Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: William K Maina; Andrea A Kim; George W Rutherford; Malayah Harper; Boniface O K'Oyugi; Shahnaaz Sharif; George Kichamu; Nicholas M Muraguri; Willis Akhwale; Kevin M De Cock Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731